Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Phase I/II interim analysis of Targretin in chronic severe hand dermatitis

Oct. 1, 2002

Genmab's HuMax-CD4 enters phase IIb trial in psoriasis

Sep. 23, 2002

Primary efficacy endpoints reached in phase III Raptiva study

Sep. 19, 2002

Amevive application to be reviewed within six months

Sep. 19, 2002

Novel IL-8 antagonists and their use in psoriasis, arthritis, etc.

Sep. 18, 2002

BMOV enters phase II for treatment of severe burns in children

Sep. 17, 2002

Novel agents for stimulating melanocyte proliferation covered by BTG patent

Sep. 13, 2002

FDA requests additional phase III trial of Cellegesic

Sep. 12, 2002

SkyePharma and Meditech announce Solarase marketing agreement

Sep. 12, 2002

Enrollment completed in Repel-CV trial

Sep. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...